Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 2
2000 3
2001 10
2002 9
2003 8
2004 6
2005 3
2006 3
2007 2
2008 3
2009 2
2010 1
2011 1
2012 1
2013 3
2015 1
2016 1
2017 1
2022 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Results by year

Filters applied: . Clear all
Page 1
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial.
Goldschmidt H, Mai EK, Bertsch U, Fenk R, Nievergall E, Tichy D, Besemer B, Dürig J, Schroers R, von Metzler I, Hänel M, Mann C, Asemissen AM, Heilmeier B, Weinhold N, Huhn S, Kriegsmann K, Luntz SP, Holderried TAW, Trautmann-Grill K, Gezer D, Klaiber-Hakimi M, Müller M, Khandanpour C, Knauf W, Scheid C, Munder M, Geer T, Riesenberg H, Thomalla J, Hoffmann M, Raab MS, Salwender HJ, Weisel KC; German-Speaking Myeloma Multicenter Group (GMMG) HD7 investigators. Goldschmidt H, et al. Lancet Haematol. 2022 Nov;9(11):e810-e821. doi: 10.1016/S2352-3026(22)00263-0. Lancet Haematol. 2022. PMID: 36328040 Clinical Trial.
Advances in the treatment of hairy-cell leukaemia.
Mey U, Strehl J, Gorschlüter M, Ziske C, Glasmacher A, Pralle H, Schmidt-Wolf I. Mey U, et al. Among authors: ziske c. Lancet Oncol. 2003 Feb;4(2):86-94. doi: 10.1016/s1470-2045(03)00980-x. Lancet Oncol. 2003. PMID: 12573350 Review.
[Immunoglobulins in PID, SID and neurological autoimmune disease].
Borte M, Baumann U, Pittrow D, Hensel M, Fasshauer M, Huscher D, Reiser M, Stangel M, Gold R, Kirch W; Liste der aktuell beitragenden Zentren, sortiert nach Postleitzahlen (mindestens ein Patient zum 1.3.2012). Borte M, et al. Dtsch Med Wochenschr. 2012 Mar;137(13):675-80. doi: 10.1055/s-0032-1304844. Epub 2012 Mar 20. Dtsch Med Wochenschr. 2012. PMID: 22434180 Review. German.
Unmentioned Side Effects.
Ziske C. Ziske C. Dtsch Arztebl Int. 2015 Oct 23;112(43):738-9. doi: 10.3238/arztebl.2015.0738b. Dtsch Arztebl Int. 2015. PMID: 26568182 Free PMC article. No abstract available.
Clostridium difficile infection in patients with neutropenia.
Gorschlüter M, Glasmacher A, Hahn C, Schakowski F, Ziske C, Molitor E, Marklein G, Sauerbruch T, Schmidt-Wolf IG. Gorschlüter M, et al. Among authors: ziske c. Clin Infect Dis. 2001 Sep 15;33(6):786-91. doi: 10.1086/322616. Epub 2001 Aug 10. Clin Infect Dis. 2001. PMID: 11512083
Minimal size MIDGE vectors improve transgene expression in vivo.
Schakowski F, Gorschlüter M, Buttgereit P, Märten A, Lilienfeld-Toal MV, Junghans C, Schroff M, König-Merediz SA, Ziske C, Strehl J, Sauerbruch T, Wittig B, Schmidt-Wolf IG. Schakowski F, et al. Among authors: ziske c. In Vivo. 2007 Jan-Feb;21(1):17-23. In Vivo. 2007. PMID: 17354609 Free article.
Partial splenectomy: uses of error.
Ziske CG, Müller T. Ziske CG, et al. Lancet. 2002 Mar 30;359(9312):1144. doi: 10.1016/s0140-6736(02)08163-1. Lancet. 2002. PMID: 11943281 No abstract available.
57 results